Markus Schlaich's guest appearances

Markus Schlaich

The Medical Journal of Australia

This podcast could save your life

OwlTail

Vol 217, Issue 11: 28 November 2022. Professor Markus Schlaich is Director of the Dobney Hypertension Centre in Perth, and Dobney Chair of Clinical Research at the University of Western Australia. His recently published research on dual endothelin antagonist aprocitentin for resistant hypertension can be found at The Lancet. His op-ed for InSight+ is free to access and can be found here. With MJA news and online editor Cate Swannell.

Vol 217, Issue 11: 28 November 2022. Professor Markus Schlaich is Director of the Dobney Hypertension Centre in Perth, and Dobney Chair of Clinical Research at the University of Western Australia. His recently published research on dual endothelin antagonist aprocitentin for resistant hypertension can be found <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02034-7/fulltext" rel="nofollow" target="_blank">at The Lancet</a>. His op-ed for InSight+ is free to access and can be found <a href="https://insightplus.mja.com.au/2022/46/exciting-times-in-treatment-of-resistant-hypertension/" rel="nofollow" target="_blank">here</a>. With MJA news and online editor Cate Swannell.

Episode 501: MJA Podcasts 2022 Episode 43: New hope for resistant hypertension, with Prof Markus Schlaich

Alta Schutte

Vol 215, Issue 11: 6 December 2021. Professor Alta Schutte is Professor of Cardiovascular Medicine at UNSW Sydney, and a Professorial Fellow at The George Institute for Global Health. Professor Markus Schlaich is the Dobney Chair of Clinical Research at the University of Western Australia. They discuss hypertension control rates in Australia and why they need urgent improvement, and how we can do that. This podcast accompanies their MJA Perspective, published here. With MJA news and online editor, Cate Swannell. 

Vol 215, Issue 11: 6 December 2021. Professor Alta Schutte is Professor of Cardiovascular Medicine at UNSW Sydney, and a Professorial Fellow at The George Institute for Global Health. Professor Markus Schlaich is the Dobney Chair of Clinical Research at the University of Western Australia. They discuss hypertension control rates in Australia and why they need urgent improvement, and how we can do that. This podcast accompanies their MJA Perspective, <a href="https://www.mja.com.au/journal/2021/216/4/uncontrolled-blood-pressure-australia-call-action" rel="nofollow" target="_blank">published here</a>. With MJA news and online editor, Cate Swannell.

Episode 451: MJA Podcasts 2021 Episode 50: Hypertension: a call to action, with Prof Alta Schutte and Prof Markus Schlaich

Hypertension is the biggest killer worldwide with an estimated 10 million deaths per year directly attributable to uncontrolled blood pressure. Also known as ‘high blood pressure’, hypertension is a chronic common condition that may cause long term damage to the heart, brain, kidneys, eyes and blood vessels, caused through the blood pressure in the arteries being persistently elevated.Join Professor Markus Schlaich from the Dobney Hypertension Centre as he discusses why it is so important to be aware of this silent killer.

Hypertension is the biggest killer worldwide with an estimated 10 million deaths per year directly attributable to uncontrolled blood pressure. Also known as ‘high blood pressure’, hypertension is a chronic common condition that may cause long term damage to the heart, brain, kidneys, eyes and blood vessels, caused through the blood pressure in the arteries being persistently elevated.Join Professor Markus Schlaich from the Dobney Hypertension Centre as he discusses why it is so important to be aware of this silent killer.